Jack Nathan Medical Corp. Announces CEO Transition and Strategic Investor Alignment

Core Viewpoint - Jack Nathan Medical Corp. is undergoing a leadership transition and strategic alignment to support its growth, optimize its balance sheet, and evaluate potential value-enhancing transactions [1][2]. Leadership Transition - Mike Marchelletta has stepped down as CEO and Vice-Chairman to lead a prospective investor syndicate for a potential strategic transaction [2]. - Michael Di Cesare, former co-founder and COO, has been appointed as Interim CEO and Vice-Chairman, bringing operational continuity and strategic insight [3]. Financial Restructuring - The company has eliminated approximately $15 million in debt and canceled about 140 million common shares previously issuable under legacy debenture financing, enhancing its capital structure and strategic flexibility [4]. - Governance measures have been implemented to strengthen shareholder confidence and long-term value creation [4][9]. Strategic Focus - The leadership transition aims to unlock new pathways for capital, partnerships, and growth, maximizing value for shareholders [5]. - The company is focused on advancing its restructuring initiatives and evaluating new growth opportunities [3][5]. Company Background - Jack Nathan Medical Corp. previously operated one of the largest retail medical clinic networks in North America, with 253 locations globally, including 82 in Canada and 171 in Mexico [10]. - The company has restructured its Canadian operations and is exploring new reverse takeover and business opportunities following its exit from Walmart Mexico operations [10].